2020 연구자 정보 (11 / 991)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Shin, Jeong-Im
(Shin, JI) ⓘ 		Korea Univ Sci & Technol, KIST Sch, Div Biomed Sci &Technol, Seoul 02792, South Korea
Korea Inst Sci & Technol, Ctr Glia Neuron Interact, Seoul 02792, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.3%] Astrocytes Control Sensory Acuity via Tonic Inhibition in the Thalamus ⓘ SCIE ⓘ 1.3 NEUROSCIENCES ⓘ cjl@ibs.re.kr
eunjicheong@yonsei.ac.kr ⓘ
Son, Taehwang
(Son, T) ⓘ 		Yonsei Univ, Sch Elect & Elect Engn, Seoul 03722, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.3%] Astrocytes Control Sensory Acuity via Tonic Inhibition in the Thalamus ⓘ SCIE ⓘ 1.3 NEUROSCIENCES ⓘ cjl@ibs.re.kr
eunjicheong@yonsei.ac.kr ⓘ
Song, Kiyeong
(Song, K) ⓘ 		Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul 03722, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.3%] Astrocytes Control Sensory Acuity via Tonic Inhibition in the Thalamus ⓘ SCIE ⓘ 1.3 NEUROSCIENCES ⓘ cjl@ibs.re.kr
eunjicheong@yonsei.ac.kr ⓘ
Woo, Junsung
(Woo, J) ⓘ 		Korea Inst Sci & Technol, Ctr Glia Neuron Interact, Seoul 02792, South Korea ⓘ
ⓘ 		0000-0003-4325-9840
Woo, Junsung ⓘ 		[JCR상위 1.3%] Astrocytes Control Sensory Acuity via Tonic Inhibition in the Thalamus ⓘ SCIE ⓘ 1.3 NEUROSCIENCES ⓘ cjl@ibs.re.kr
eunjicheong@yonsei.ac.kr ⓘ
Yoon, Bo-Eun
(Yoon, BE) ⓘ 		Dankook Univ, Coll Nat Sci, Dept Mol Biol, Cheonan 31116, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.3%] Astrocytes Control Sensory Acuity via Tonic Inhibition in the Thalamus ⓘ SCIE ⓘ 1.3 NEUROSCIENCES ⓘ cjl@ibs.re.kr
eunjicheong@yonsei.ac.kr ⓘ
Alsina, Angel
(Alsina, A) ⓘ 		제1저자 교신저자 Tampa Gen Hosp, Transplant & Specialty Serv, Tampa, FL 33606 USA ⓘ E-5347-2010
Alsina, Angel ⓘ
ⓘ 		[JCR상위 1.5%] Subsequent anticancer procedures following first-line lenvatinib (LEN): A post hoc analysis from the phase III REFLECT study in unresectable hepatocellular carcinoma (uHCC)
[JCR상위 7.1%] Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma ⓘ 		SCIE ⓘ 1.5 ONCOLOGY
GASTROENTEROLOGY & HEPATOLOGY ⓘ 		aalsina@tgmg.org ⓘ
Baek, Dong Won
(Baek, DW) ⓘ 		제1저자 교신저자 Kyungpook Natl Univ, Dept Hematol Oncol, Kyungpook Natl Univ Hosp, Sch Med, 130 Dongdeok Ro, Daegu 41944, South Korea
Kyungpook Natl Univ Hosp, Daegu, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Hematol Oncol, Sch Med, 130 Dongdeok Ro, Daegu 41944, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, 130 Dongdeok Ro, Daegu 41944, South Korea
Kyungpook Natl Univ, Canc Res Inst, Dept Oncol Hematol, Chilgok Hosp,Sch Med, 807 Hoguk Ro, Daegu 41404, South Korea
Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Oncol Hematol, Daegu, South Korea
Kyungpook Natl Univ, Canc Res Inst, Dept Oncol Hematol, Chilgok Hosp,Sch Med, 807 Hogukno, Daegu 41404, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, Daegu 41944, South Korea ⓘ
ⓘ
ⓘ 		Apparent diffusion coefficient as a valuable quantitative parameter for predicting clinical outcomes in patients with newly diagnosed primary CNS lymphoma
[JCR상위 1.5%] Apparent diffusion coefficient as a valuable quantitative parameter for predicting clinical outcomes in patients with newly diagnosed primary CNS lymphoma.
[JCR상위 22.0%] Favorable Long-term Outcomes with Autologous Stem Cell Transplantation for High Risk Patients with Multiple Myeloma Who are Positive at FDG-PET/CT
[JCR상위 80.4%] Quantitative Assessment of Interim PET/CT Could Have More Prognostic Relevance than Visual Assessment for Predicting Clinical Outcome of Extranodal Diffuse Large B Cell Lymphoma
[JCR상위 29.3%] COVID-19 transmission and blood transfusion: A case report
[JCR상위 61.8%] The Therapeutic Effect of Cyclin-Dependent Kinase 4/6 Inhibitor on Relapsed Ectopic Male Breast Cancer
[JCR상위 99.8%] Ischemic stroke as an initial presentation of primary bone marrow lymphoma
[JCR상위 80.4%] Prognostic Impact of the Neoadjuvant Rectal Score as Compared With the Tumor Regression Grade and Yield Pathologic TNM Stage in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy
[JCR상위 42.4%] High expression of microRNA-199a-5p is associated with superior clinical outcomes in patients with locally advanced rectal cancer
[JCR상위 65.1%] Hypomethylating agent-based post-transplant strategies to maximize the outcome of high-risk acute myeloid leukemia after allogeneic stem cell transplantation ⓘ 		ESCI
SCIE ⓘ 		1.5 HEMATOLOGY
ONCOLOGY
IMMUNOLOGY
TRANSPLANTATION
MEDICINE, RESEARCH & EXPERIMENTAL
INFECTIOUS DISEASES
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
CLINICAL NEUROLOGY ⓘ 		jhmoon@knu.ac.kr
drydh1685@hotmail.com
baekdw83@gmail.com
yschae@knu.ac.kr
ghkdwocns@gmail.com
jkk21c@knu.ac.kr
keunhur@knu.ac.kr
sksohn@knu.ac.kr ⓘ
Baek, Jin Ho
(Baek, JH) ⓘ 		제1저자 Kyungpook Natl Univ, Canc Res Inst, Dept Oncol Hematol, Chilgok Hosp,Sch Med, 807 Hogukno, Daegu 41404, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5%] The relationship between tumor-infiltrating lymphocytes, PD-L1 expression, and clinical outcomes of Asian melanoma patients treated with anti-PD-1 antibody.
[JCR상위 80.4%] Prognostic Impact of the Neoadjuvant Rectal Score as Compared With the Tumor Regression Grade and Yield Pathologic TNM Stage in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy ⓘ 		SCIE ⓘ 1.5 ONCOLOGY
MEDICINE, RESEARCH & EXPERIMENTAL ⓘ 		jkk21c@knu.ac.kr ⓘ
Baldwin, Rae Lynn
(Baldwin, RL) ⓘ 		ⓘ
ⓘ
ⓘ 		[JCR상위 1.5%] Subsequent anticancer procedures following first-line lenvatinib (LEN): A post hoc analysis from the phase III REFLECT study in unresectable hepatocellular carcinoma (uHCC) ⓘ SCIE ⓘ 1.5 ONCOLOGY ⓘ ⓘ
Blanc, Jean-Frederic
(Blanc, JF) ⓘ 		ⓘ
ⓘ
ⓘ 		[JCR상위 1.5%] Subsequent anticancer procedures following first-line lenvatinib (LEN): A post hoc analysis from the phase III REFLECT study in unresectable hepatocellular carcinoma (uHCC) ⓘ SCIE ⓘ 1.5 ONCOLOGY ⓘ ⓘ
Cheng, Ann-Lii
(Cheng, AL) ⓘ 		Natl Taiwan Univ Hosp, Dept Med Oncol, Taipei, Taiwan
Natl Taiwan Univ, Ctr Canc, Taipei, Taiwan ⓘ 		ACM-0936-2022
Cheng, Ann-Lii ⓘ
ⓘ 		[JCR상위 1.5%] Subsequent anticancer procedures following first-line lenvatinib (LEN): A post hoc analysis from the phase III REFLECT study in unresectable hepatocellular carcinoma (uHCC)
[JCR상위 7.1%] Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma ⓘ 		SCIE ⓘ 1.5 ONCOLOGY
GASTROENTEROLOGY & HEPATOLOGY ⓘ 		aalsina@tgmg.org ⓘ
Choi, Hyeokjin
(Choi, H) ⓘ 		ⓘ
ⓘ
ⓘ 		[JCR상위 1.5%] The relationship between tumor-infiltrating lymphocytes, PD-L1 expression, and clinical outcomes of Asian melanoma patients treated with anti-PD-1 antibody. ⓘ SCIE ⓘ 1.5 ONCOLOGY ⓘ ⓘ
Daniele, Bruno
(Daniele, B) ⓘ 		Azienda Osped G Rummo, Dept Oncol, Benevento, Italy
Osped Mare, Naples, Italy ⓘ 		IAR-5511-2023
Daniele, Bruno ⓘ
ⓘ 		[JCR상위 1.5%] Subsequent anticancer procedures following first-line lenvatinib (LEN): A post hoc analysis from the phase III REFLECT study in unresectable hepatocellular carcinoma (uHCC)
[JCR상위 7.1%] Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma ⓘ 		SCIE ⓘ 1.5 ONCOLOGY
GASTROENTEROLOGY & HEPATOLOGY ⓘ 		aalsina@tgmg.org ⓘ
Evans, T. R. Jeffry
(Evans, TRJ) ⓘ 		ⓘ
ⓘ
ⓘ 		[JCR상위 1.5%] Subsequent anticancer procedures following first-line lenvatinib (LEN): A post hoc analysis from the phase III REFLECT study in unresectable hepatocellular carcinoma (uHCC) ⓘ SCIE ⓘ 1.5 ONCOLOGY ⓘ ⓘ
Finn, Richard S.
(Finn, RS) ⓘ 		Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Med Ctr, Santa Monica, CA USA ⓘ
ⓘ
ⓘ 		[JCR상위 1.5%] Subsequent anticancer procedures following first-line lenvatinib (LEN): A post hoc analysis from the phase III REFLECT study in unresectable hepatocellular carcinoma (uHCC)
[JCR상위 7.1%] Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma ⓘ 		SCIE ⓘ 1.5 ONCOLOGY
GASTROENTEROLOGY & HEPATOLOGY ⓘ 		aalsina@tgmg.org ⓘ
페이지 이동: